Hosptial for Special Surgery
New York, NY, United States
Dr. Spiera is the Director of the Vasculitis and Scleroderma Program at the Hospital for Special Surgery and a Professor of Clinical Medicine at Weill Cornell Medical College. He is the principal investigator in several clinical trials and observational studies focusing on scleroderma and vasculitis. Dr. Spiera specializes in the treatment of various rheumatologic conditions including scleroderma, vasculitis, systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, and many other conditions. He has authored over 150 publications relating to scleroderma, vasculitis, and other rheumatic diseases.
Great Debate: Should PMR and GCA Be Treated with Advanced Therapies at Disease Onset?
Monday, November 13, 2023
9:00 AM – 9:45 AM PT
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); chemocentryx: Grant/Research Support (Ongoing); corbus: Grant/Research Support (Ongoing); Formation Biologics: Grant/Research Support (Ongoing); GSK: Consultant (Ongoing), Grant/Research Support (Ongoing); Inflarx: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Principia: Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing)
232: The Inflammatory Role of the Eosinophil in EGPA
Tuesday, November 14, 2023
1:30 PM – 2:15 PM PT
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); chemocentryx: Grant/Research Support (Ongoing); corbus: Grant/Research Support (Ongoing); Formation Biologics: Grant/Research Support (Ongoing); GSK: Consultant (Ongoing), Grant/Research Support (Ongoing); Inflarx: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Principia: Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing)
